Patent · US Active

Therapeutic agent for osteoporosis

US9149471B2 · kind B2 · utility

6Cited by

1References

2Claims

0Family size

Assignees

NATIONAL UNIVERSITY ORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY · JP
Taiho Pharmaceutical Co., Ltd. · JP

Inventors

Chisato Miyaura · Fuchu, JP
Masaki Inada · Fuchu, JP
Hidenori Fujita · Tsukuba, JP

Key dates

Filing date	Sep 30, 2013
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Nov 10, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

To provide an agent for treating osteoporosis, comprising an acyl thiourea compound represented by the following formula (I) or a salt thereof as an active ingredient:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.